BRIEF published on 03/06/2026 at 10:41, 16 days 20 hours ago Eckert & Ziegler propose un dividende de 0,22 € par action pour 2025 Assemblée Générale Annuelle Relations Avec Les Investisseurs Proposition De Dividende Exercice Financier 2025 Eckert Et Ziegler
BRIEF published on 03/06/2026 at 10:41, 16 days 20 hours ago Eckert & Ziegler Proposes €0.22 Dividend per Share for 2025 Annual General Meeting Investor Relations Eckert & Ziegler Dividend Proposal Financial Year 2025
PRESS RELEASE published on 03/06/2026 at 10:36, 16 days 20 hours ago EQS-Adhoc: Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025 Eckert & Ziegler SE plans dividend of €0.22 per share for 2025, subject to AGM approval. Detailed financial statements to be released on March 26, 2026 Shareholders Annual Financial Statements Dividend Eckert & Ziegler SE 2025 Financial Year
BRIEF published on 02/26/2026 at 07:05, 24 days 23 hours ago Eckert & Ziegler s'associe à Molecular Partners pour le développement de Radio-DARPin Partenariat Traitement Du Cancer Produits Radiopharmaceutiques Eckert Et Ziegler Radio-DARPin
BRIEF published on 02/26/2026 at 07:05, 24 days 23 hours ago Eckert & Ziegler Partners with Molecular Partners for Radio-DARPin Development Partnership Cancer Treatment Eckert & Ziegler Radiopharmaceuticals Radio-DARPin
PRESS RELEASE published on 02/26/2026 at 07:00, 25 days ago Eckert & Ziegler Enters Partnership with Molecular Partners to Support Development of Radio-DARPin Therapeutics Eckert & Ziegler SE partners with Molecular Partners to develop Radio-DARPin therapeutics, leveraging DARPin technology for cancer treatment with alpha emitters Partnership Eckert & Ziegler Therapeutics Radio-DARPin Molecular Partners
BRIEF published on 02/16/2026 at 11:05, 1 month 6 days ago Eckert & Ziegler and UJF Boost Actinium-225 Production Eckert & Ziegler Radiopharmaceuticals Production Increase Actinium-225 Global Supply
BRIEF published on 02/16/2026 at 11:05, 1 month 6 days ago Eckert & Ziegler et l'UJF stimulent la production d'actinium-225 Produits Radiopharmaceutiques Augmentation De La Production Actinium-225 Approvisionnement Mondial Eckert Et Ziegler
PRESS RELEASE published on 02/16/2026 at 11:00, 1 month 6 days ago Eckert & Ziegler and UJF Significantly Increase Production Volume for Actinium-225 Eckert & Ziegler SE and UJF increase Actinium-225 production volume, addressing global demand for alpha-emitting radionuclides in targeted radiopharmaceutical applications Eckert & Ziegler Production Volume Radiopharmaceuticals Actinium-225 UJF
BRIEF published on 02/05/2026 at 09:05, 1 month 17 days ago Eckert & Ziegler SE: Steady Growth and Strategic Positioning Financial Results Market Expansion Nuclear Medicine Radioisotopes Therapeutic Isotopes
Published on 03/23/2026 at 02:00, 5 hours 1 minute ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 17 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 06:47, 13 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/23/2026 at 03:35, 3 hours 25 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 12:23, 18 hours 38 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 19:00, 2 days 12 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 12 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 12 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 12 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
